Connect with us

Health

Pfizer posts $4.9 billion profit in the first quarter as vaccine strategy pays off – The Boston Globe

Once viewed as a marketing machine for blockbuster treatments such as Viagra and Lipitor, Pfizer has transformed itself into a powerhouse for delivering drugs that…

Published

on

Article feature image

Pfizer on Tuesday almost doubled its sales projections for the COVID-19 vaccine this year, from $15 billion to roughly $26 billion. The partners expect to be able to deliver about 2.5 billion vaccine doses this year, including 300 million doses for the U.S., and already are prepping for what could become annual booster shots.
Pfizer got into the low-profile, low-profit vaccine field in 2009 when it acquired Wyeth and its then-experimental pneumococcal vaccine. That vaccine, Prevnar, which protects…

Click here to view the original article.

You might also like ...

Article feature image
Second-hand smoke can raise your odds for heart failure – Medical Xpress
Article feature image
Heart Disease Often Comes in Pairs – WebMD
Article feature image
Spinraza: SMA patients win fight over treatment loophole – BBC News